Similar articles for PMID: 28628772

Year	Number of Results
1994	1
1996	1
2000	1
2002	1
2003	1
2004	2
2006	2
2007	3
2008	2
2009	3
2010	1
2011	3
2012	5
2013	6
2014	9
2015	16
2016	13
2017	14
2018	6
2019	5
2020	8
2021	8
2022	11
2023	4
2024	0

1

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation.

Carbognin L, Sperduti I, Fabi A, Dieci MV, Kadrija D, Griguolo G, Pilotto S, Guarneri V, Zampiva I, Brunelli M, Orvieto E, Nortilli R, Fiorio E, Parolin V, Manfrin E, Caliò A, Nisticò C, Pellini F, Scarpa A, Pollini GP, Conte P, Tortora G, Bria E. Carbognin L, et al. Breast. 2017 Oct;35:21-26. doi: 10.1016/j.breast.2017.06.005. Epub 2017 Jun 17. Breast. 2017. PMID: 28628772

2

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.

Carbognin L, Sperduti I, Brunelli M, Marcolini L, Nortilli R, Pilotto S, Zampiva I, Merler S, Fiorio E, Filippi E, Manfrin E, Pellini F, Bonetti F, Pollini GP, Tortora G, Bria E. Carbognin L, et al. J Exp Clin Cancer Res. 2016 Mar 22;35:50. doi: 10.1186/s13046-016-0325-z. J Exp Clin Cancer Res. 2016. PMID: 27000271 Free PMC article.

3

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.

Adachi Y, Ishiguro J, Kotani H, Hisada T, Ichikawa M, Gondo N, Yoshimura A, Kondo N, Hattori M, Sawaki M, Fujita T, Kikumori T, Yatabe Y, Kodera Y, Iwata H. Adachi Y, et al. BMC Cancer. 2016 Mar 25;16:248. doi: 10.1186/s12885-016-2275-4. BMC Cancer. 2016. PMID: 27015895 Free PMC article.

4

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma.

Engels CC, Fontein DB, Kuppen PJ, de Kruijf EM, Smit VT, Nortier JW, Liefers GJ, van de Velde CJ, Bastiaannet E. Engels CC, et al. Br J Cancer. 2014 Jul 29;111(3):532-8. doi: 10.1038/bjc.2014.338. Epub 2014 Jun 17. Br J Cancer. 2014. PMID: 24937677 Free PMC article.

5

Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.

Zengel B, Yararbas U, Duran A, Uslu A, Elıyatkın N, Demırkıran MA, Cengiz F, Şimşek C, Postacı H, Vardar E, Durusoy R. Zengel B, et al. Breast Cancer. 2015 Jul;22(4):374-81. doi: 10.1007/s12282-013-0489-8. Epub 2013 Aug 8. Breast Cancer. 2015. PMID: 23925582

6

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.

Metzger-Filho O, Ferreira AR, Jeselsohn R, Barry WT, Dillon DA, Brock JE, Vaz-Luis I, Hughes ME, Winer EP, Lin NU. Metzger-Filho O, et al. Oncologist. 2019 Jul;24(7):e441-e449. doi: 10.1634/theoncologist.2018-0363. Epub 2018 Dec 5. Oncologist. 2019. PMID: 30518616 Free PMC article.

7

Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.

Wang T, Ma Y, Wang L, Liu H, Chen M, Niu R. Wang T, et al. Tumour Biol. 2015 Aug;36(8):6113-24. doi: 10.1007/s13277-015-3293-6. Epub 2015 Mar 25. Tumour Biol. 2015. PMID: 25804795

8

Survival analysis between patients with invasive ductal and invasive lobular breast cancer.

Dian D, Herold H, Mylonas I, Scholz C, Janni W, Sommer H, Friese K. Dian D, et al. Arch Gynecol Obstet. 2009 Jan;279(1):23-8. doi: 10.1007/s00404-008-0662-z. Epub 2008 May 1. Arch Gynecol Obstet. 2009. PMID: 18449551

9

Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.

Flores-Díaz D, Arce C, Flores-Luna L, Reynoso-Noveron N, Lara-Medina F, Matus JA, Bargallo-Rocha E, Pérez V, Villarreal-Garza C, Cabrera-Galeana P, Mohar A. Flores-Díaz D, et al. Breast Cancer Res Treat. 2019 Jul;176(1):243-249. doi: 10.1007/s10549-019-05234-8. Epub 2019 Apr 17. Breast Cancer Res Treat. 2019. PMID: 30997623

10

Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.

Wong H, Lau S, Cheung P, Wong TT, Parker A, Yau T, Epstein RJ. Wong H, et al. BMC Cancer. 2014 Nov 10;14:826. doi: 10.1186/1471-2407-14-826. BMC Cancer. 2014. PMID: 25385074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year